Home – WebsiteMike
Description: Incendia Therapeutics is a precision oncology biotech company dedicated to reprogramming the tumor microenvironment with the express intent of bringing recalcitrant cancers into submission.
At Parthenon Therapeutics, we are reprogramming the tumor microenvironment to beat cancers
As our understanding of the mechanisms of cancer resistance has grown, so too have our strategies to combat/address those biological challenges. However, despite recent advances in anti-cancer therapy, many people living with cancer continue to have low response and poor prognosis. Parthenon's approach is informed by our improved understanding of the important role of the tumor microenvironment in fighting disease.
We are scientists, drug developers, clinicians, pathologists, bioinformaticians, engineers, innovators, and cancer warriors redefining the treatment landscape for patients with recalcitrant cancers.
Home – WebsiteMike